Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Is there an allegiance bias on the efficacy of systemic therapy? A three-level meta- regression analysis
Niels Braus1, Christoph Flückiger2, Robin Gräfenkämper1
1School of Psychology and Psychotherapy, Clinical Psychology and Psychotherapy III, Witten/Herdecke University, Witten, Germany.
Objective:
Allegiance bias affects the reproducibility of psychotherapy outcomes, but its impact in systemic therapy (ST) remains largely unexplored.
Method:
Two meta-analyses were conducted: Study 1 with 42 RCTs (364 effect sizes) for children and adolescents, as well as Study 2 with 30 RCTs (161 effect sizes) for adults. Allegiance was measured using a comprehensive rating scale across researcher, therapist, trainer, and supervisor levels. Furthermore, risk of bias (RoB) was assessed using the adapted tool for psychotherapy. Three-level meta-regressions were performed, controlling for dosage.
Results:
No significant moderating effect of the overall allegiance score was found in either study, Study 1: F(2, 361) = .88, p = .42, k = 364, s = 42; Study 2: F(2, 158) = 2.35, p = .10, k = 161, s = 30 . Researcher allegiance predicted higher treatment efficacy in Study 1 (β = .14, p = .02) but not in Study 2 (β = .02, p = .82). A significant moderating effect of RoB emerged in Study 2 (F(8, 151) = 3.02, p = .004, k = 161, s = 30), indicating that higher RoB was associated with larger effects favoring ST. This pattern was absent in Study 1 (F(8,355) = 1.04, p = .41, k = 364, s = 42).
Conclusion:
The findings underscore the role of researcher allegiance investigating ST for children and adolescents and RoB in ST for adults, highlighting the need for transparent methods and replication efforts.
Related Concept Videos
Bias in Epidemiological Studies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Comparing the Survival Analysis of Two or More Groups
Dose-Response Relationship: Potency and Efficacy